Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet.

AJR Am J Roentgenol

Division of Nuclear Medicine, Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA 02215-5400, USA.

Published: February 2008

Objective: Myocardial 18F-FDG uptake in PET scans in patients prepared by the usual fasting protocol may result in difficulties in interpretation because variable uptake may yield false-positive results regarding mediastinal abnormalities. We aimed to analyze, retrospectively, the effect of diet on myocardial FDG uptake.

Materials And Methods: The "fasting" group comprised 101 consecutive patients before a clinical change in the patient preparation protocol. The "new diet" group comprised 60 consecutive patients after the clinical protocol change who were directed to consume a very high-fat, low-carbohydrate, protein-permitted (VHFLCPP) diet before FDG injection. All patients were given a questionnaire that was used to verify diet adherence. Nonadherers or patients failing to complete questionnaires were excluded from analysis. Myocardial uptake was evaluated by measuring the maximum standardized uptake value (SUVmax) in areas defined by CT as being cardiac.

Results: The average SUVmax for the fasting group (n = 101) was 8.8 +/- 5.7, and the average SUVmax for the VHFLCPP group (n = 60) was 3.9 +/- 3.6. The one-tailed Student's t test yielded a p value of < 0.00001.

Conclusion: A VHFLCPP meal eaten 3-6 hours before FDG injection suppresses myocardial FDG uptake. This should facilitate definition of mediastinal abnormalities on FDG PET, particularly with stand-alone PET. Furthermore, this patient preparation protocol may permit the detection of biologically active coronary artery disease.

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.07.2409DOI Listing

Publication Analysis

Top Keywords

myocardial 18f-fdg
8
18f-fdg uptake
8
high-fat low-carbohydrate
8
mediastinal abnormalities
8
myocardial fdg
8
group comprised
8
consecutive patients
8
patients clinical
8
patient preparation
8
preparation protocol
8

Similar Publications

This study aimed to investigate the effects of chronic sympathoinhibition on glucose uptake by the myocardium and by the skeletal muscle in an animal model of obesity associated with leptin signaling deficiency. 6 obese Zucker rats (OZR) and 6 control Lean Zucker rats (LZR) were studied during basal conditions, chronic clonidine administration (30 days, 300 µg/kg), and washout recovery period. Glucose uptake in the myocardium and in the skeletal muscle was measured using positron emission tomography (PET) and 2-[18F] fluoro-2-deoxy-D-glucose ([18F]FDG).

View Article and Find Full Text PDF

Objectives: The development and progression of chronic heart failure (CHF), hypertrophy, and remodeling strongly correlate with myocardial inflammation and oxidative stress. S-adenosylmethionine (SAMe), available as a dietary supplement, exerts anti-inflammatory and antioxidant effects. Previous reports show that by regulating angiogenesis and fibrosis, S-adenosyl-L-methionine improves ventricular remodeling.

View Article and Find Full Text PDF

 Texture and radiomic analysis characterize the lesion's phenotype and evaluate its microenvironment in quantitative terms. The aim of this study was to investigate the role of textural features of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET/CT) images in differentiating patients with cardiac sarcoidosis (CS) from patients with physiologic myocardial uptake.  This is a retrospective, single-center study of 67 patients, 17 diagnosed CS patients, and 50 non-CS patients.

View Article and Find Full Text PDF

Inflammation is an important driver of disease in the context of atherosclerosis, and several landmark trials have shown that targeting inflammatory pathways can reduce cardiovascular event rates. However, the high cost and potentially serious adverse effects of anti-inflammatory therapies necessitate more precise patient selection. Traditional biomarkers of inflammation, such as high-sensitivity C-reactive protein (hsCRP), show an association with cardiovascular risk on a population level, but do not have specificity for local plaque inflammation.

View Article and Find Full Text PDF

Can FDG PET Serve as a Clinically Relevant Tool for Detecting Active Non-sarcoidotic Myocarditis?

Nucl Med Mol Imaging

December 2024

Department of Nuclear Medicine, Chonnam National University Hospital, 42, Jebong-ro, Dong-gu, Gwangju, 61469 Republic of Korea.

Article Synopsis
  • The diagnosis of myocarditis primarily relies on non-invasive imaging techniques due to the low effectiveness of endomyocardial biopsy and the need to identify various possible causes.
  • Cardiac magnetic resonance imaging has become the go-to method for managing myocarditis, especially during the COVID-19 pandemic, due to the unclear and varied symptoms of the condition.
  • The article examines the current evidence for diagnosing non-sarcoidotic myocarditis using non-invasive imaging, particularly focusing on the potential usefulness of F-18 fluorodeoxyglucose PET scans for detecting active inflammation.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!